About Incircular
Incircular develops stabilized protein therapeutics using a proprietary structure-guided approach. Founded in 2021 as a spin-out from VU University Amsterdam, the company builds on original research in in situ protein cyclization to address the limitations of conventional biologics.
Our team
Incircular is led by a multidisciplinary team combining expertise in chemistry, structural biology, and business development. Together with experienced molecular biologists and biotech specialists, the team has more than 50 years of combined experience across startups, scale-ups, and therapeutic development.
Saskia Neubacher
CSO & Co-Founder
Felix Paulußen
Co-Managing Director
Antrea Kyriakidou
Business Development Manager
Martin Bakker
Business Development Advisor
Tom Grossmann
Scientific Advisor & Co-Founder
Sven Hennig
Scientific Advisor & Co-Founder
Rob Pieters
Clinical Advisor
More stability. More impact.
Our mission is to unlock the full potential of therapeutic proteins, not by redesigning them, but by reinforcing what already works. We use INCYPRO to extend half-life, enhance stability, and bring clarity to performance. Beyond therapeutics, we work with partners to apply this stability across research tools and industrial enzymes, wherever precision matters.
Contact us to learn more about our work or explore collaboration opportunities

